SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
许安华
Lv5
1465 积分
2021-11-18 加入
最近求助
最近应助
互助留言
Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review
1天前
待确认
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials
2天前
已完结
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intraabdominal infections
16天前
已完结
Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study
22天前
已完结
Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma
24天前
已完结
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions
24天前
已完结
Randomized, Multicenter, Double-Blind Study of Efficacy, Safety, And Tolerability of Intravenous Ertapenem Versus Piperacillin/Tazobactam in Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults
1个月前
已完结
Ertapenem Once Daily Versus Piperacillin‐Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin‐Structure Infections in Adults: Results of a Prospective, Randomized, Double‐Blind Multicenter Study
1个月前
已关闭
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia
1个月前
已完结
A Study Evaluating the Efficacy, Safety, and Tolerability of Ertapenem versus Ceftriaxone for the Treatment of Community‐Acquired Pneumonia in Adults
1个月前
已完结
没有进行任何应助
已查询到【积分已退回】
1个月前
信息有误【积分已退回】
1年前
已获取到【积分已退回】
1年前
预印本,作者已撤回,无法下载【积分已退回】
1年前
感谢
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论